Furtim Therapeutics LLC

4000 Mason Rd. STE 304 New Ventures Facility/Fluke Hal
Seattle, WA 98105

SBIR Award Summary

Total Number of Awards 1
Total Value of Awards $225K
First Award Date 07/01/17
Most Recent Award Date 07/01/17

Key Personnel

Last Name Name Awards Contact
Sellhorn George Sellhorn 2 Message

1 Award Won

Phase 1 SBIR

Agency: National Science Foundation
Topic: BM
Budget: 07/01/17 - 04/30/18

This SBIR Phase I project aims to develop a superior alternative to the current frontline treatment for children?s Acute Lymphoblastic Leukemia (ALL). The primary treatment option has a host of negative side effects resulting from the use of poly(ethylene glycol) (PEG) conjugated to the L-asparaginase enzyme. Antibodies made against this drug ca...